Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Questionable methods of cancer management: Cancell/Entelev.

[No authors listed]

CA Cancer J Clin. 1993 Jan-Feb;43(1):57-62. No abstract available.

2.

Vitamin C as a cancer treatment: state of the science and recommendations for research.

Tamayo C, Richardson MA.

Altern Ther Health Med. 2003 May-Jun;9(3):94-101. Review. No abstract available.

PMID:
12776480
3.

The use of antioxidant therapies during chemotherapy.

Drisko JA, Chapman J, Hunter VJ.

Gynecol Oncol. 2003 Mar;88(3):434-9. Review.

PMID:
12648599
4.

Systemic treatment and new developments in advanced prostate cancer.

Sternberg CN.

Eur J Cancer. 2001 Oct;37 Suppl 7:S147-57. Review. No abstract available.

PMID:
11887986
5.

Drug watch 2006: cancer therapies.

Dest V.

RN. 2006 Jun;69(6):31-6; quiz 37. Review. No abstract available.

PMID:
16796271
7.

Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.

Grossman HB, Stenzl A, Moyad MA, Droller MJ.

Scand J Urol Nephrol Suppl. 2008 Sep;(218):213-33. doi: 10.1080/03008880802284258. Review.

PMID:
18815935
8.

Nutraceuticals and cancer management.

Tripathi YB, Tripathi P, Arjmandi BH.

Front Biosci. 2005 May 1;10:1607-18. Review.

PMID:
15769650
9.

Clinical cancer research 2001: new agents and therapies.

Verweij J, de Vries EG.

Drug Resist Updat. 2001 Aug;4(4):217-23. Review. No abstract available.

PMID:
11991676
10.

Dietary supplements in patients with cancer: risks and key concepts, part 1.

Michaud LB, Karpinski JP, Jones KL, Espirito J.

Am J Health Syst Pharm. 2007 Feb 15;64(4):369-81. Review.

PMID:
17299176
12.

Complementary and alternative cancer therapies: past, present and the future scenario.

Shukla Y, Pal SK.

Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):3-14. Review.

13.

Ceramide and sphingosine 1-phosphate in anti-cancer therapies.

Perry DK, Kolesnick RN.

Cancer Treat Res. 2003;115:345-54. Review. No abstract available.

PMID:
12613204
14.

[Questionable methods in cancer therapy].

Jirillo A, Falci C.

Recenti Prog Med. 2005 Jul-Aug;96(7-8):344-51. Review. Italian.

PMID:
16209114
15.

Complementary and alternative therapies for advanced prostate cancer.

Smith MR.

Hematol Oncol Clin North Am. 2001 Jun;15(3):559-71. Review.

PMID:
11525297
16.

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.

Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T.

Crit Rev Oncol Hematol. 2005 Jan;53(1):35-69. Review.

PMID:
15607934
17.

Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

Skirvin JA, Lichtman SM.

Drugs Aging. 2002;19(1):25-42. Review.

PMID:
11929325
18.

Cyclooxygenases in cancer: chemoprevention and sensitization to conventional therapies.

Jeon YT, Song YS.

Mini Rev Med Chem. 2006 Jul;6(7):827-33. Review.

PMID:
16842132
19.

Unproven (questionable) cancer therapies.

Brigden ML.

West J Med. 1995 Nov;163(5):463-9. Review.

20.

Comparing antibody and small-molecule therapies for cancer.

Imai K, Takaoka A.

Nat Rev Cancer. 2006 Sep;6(9):714-27. Review.

PMID:
16929325
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk